CBD for Seizures
Orrin Devinsky, a neurologist at New York University Langone Medical Center published the results from the largest study to date of a cannabis-based drug for treatment-resistant epilepsy in The Lancet Neurology.
The researchers treated 162 patients with an extract of 99 percent CBD, and monitored them for 12 weeks. This treatment was given as an add-on to the patients’ existing medications and the trial was open-label meaning everybody knew what they were getting.
The researchers reported the intervention reduced motor seizures at a rate of 36% and 2% of patients became entirely seizure free. Stories of cannabis’s abilities to alleviate seizures have been around for about 150 years.
Both patients and scientists have started to focus on the potential benefits of CBD instead of THC. The trial led by Devinsky is currently the most robust assessment of CBD’s effect on epilepsy. The study is an important step in establishing CBD as an effective epilepsy treatment.
Evidence suggesting that CBD is effective against treatment-resistant epilepsy may be growing but scientists still know very little about how it works. In the meantime most clinicians and researchers, advise “cautious optimism” when considering CBD as an epilepsy treatment.
The FDA has already approved human trials specifically on epileptic children in order to study the role of CBD oil in curing epilepsy in a more specific fashion. CBD is being taken very seriously as a potential cure for epileptic seizures in children.
For instance, an 11-year-old boy who was dying from severe epilepsy has not had any seizures for 300 days since being prescribed CBD. He began treatment in early 2016 and has not had one seizure to date.
His mother, Charlotte Caldwell, said Billy Caldwell used to suffer up to 100 seizures per day, has now not had a single seizure for 300 days. This type of anecdotal evidence are the reports the FDA is using to gather enough data to potentially legally approve CBD as a medicine.